The serendipitous discovery of exendin-4 led to the development of exenatide immediate-release (exenatide IR, Byetta), a synthetic version of exendin-4 with C-terminal amidation to enhance its stability [ Figure 2 , Table 1 ], which became the first FDA-approved GLP-1RA in 2005 for the treatment of T2DM in adults [ Table 2 ]
10.1089/acm.2004.10.1033 26
Nutr J 14:107 Milutinovic PS, Alcorn JF, Englert JM, Crum LT, Oury TD (2012) The receptor for advanced glycation end products is a central mediator of asthma pathogenesis
10.3390/nu13082750 51 TakayaK.SuzukiT.MotohashiH.OnoderaK.SatomiS.KenslerT
You can't visually detect denaturation
International Journal of Molecular Sciences, 24 (3), 2370